ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,215Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 680

$1.43M Total Retail Price of All Prescriptions

Rank: 26 out of 680

893 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 893 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 893 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 19,006 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 790 621 S3 1 4
LEVOTHYROXINE SODIUM 774 690 2 2
SIMVASTATIN 620 459 3 3
AMLODIPINE BESYLATE 618 501 4 1
FUROSEMIDE 572 426 5 6
OMEPRAZOLE 529 452 6 7
METFORMIN HCL 522 386 7 8
PRAVASTATIN SODIUM 492 401 8 10
METOPROLOL TARTRATE 385 300 9 12
NEXIUM 384 270 10 16
METOPROLOL SUCCINATE 381 332 11 13
LISINOPRIL 362 228 12 5
BENAZEPRIL HCL 350 302 13 40
SERTRALINE HCL 347 271 14 28
ZOLPIDEM TARTRATE 302 246 15 17
HYDROCHLOROTHIAZIDE 279 232 16 9
GABAPENTIN 259 189 17 15
ATORVASTATIN CALCIUM 257 227 18 11
MELOXICAM 253 184 19 24
OLANZAPINE 248 160 20 116
POTASSIUM CHLORIDE 234 156 21 14
ESCITALOPRAM OXALATE 233 204 22 45
TAMSULOSIN HCL 221 129 23 34
ATENOLOL 218 203 24 19
RISPERIDONE 214 122 25 80
CLOPIDOGREL 208 181 26 26
CRESTOR 206 186 27 25
DIVALPROEX SODIUM 206 105 27 110
TRIAMTERENE-HCTZ 205 164 29 52
GLYBURIDE 186 167 R 30 85
METFORMIN HCL ER 184 152 31 54
NIFEDIPINE ER 182 147 32 75
NAMENDA 182 172 32 35
WARFARIN SODIUM 182 163 32 20
KLOR-CON 10 182 119 32 184
TRAZODONE HCL 169 100 36 48
TRAMADOL HCL 169 146 36 18
PLAVIX 163 143 38 39
LANTUS 162 94 39 49
HALOPERIDOL 161 77 40 193
LACTULOSE 157 65 41 92
DONEPEZIL HCL 157 144 41 27
CITALOPRAM HBR 156 110 43 22
BENZTROPINE MESYLATE 154 63 R 44 137
CYMBALTA 148 78 45 46
AMOX TR-POTASSIUM CLAVULANATE 143 105 46 124
QUETIAPINE FUMARATE 142 78 47 64
PHENYTOIN SODIUM EXTENDED 140 63 48 115
PANTOPRAZOLE SODIUM 140 116 48 30
DIVALPROEX SODIUM ER 137 37 50 148
CARVEDILOL 136 98 51 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 115 52 37
DIOVAN 131 96 53 31
ISOSORBIDE MONONITRATE ER 124 124 54 59
MIRTAZAPINE 123 79 55 78
ALLOPURINOL 123 116 55 33
PREDNISONE 121 94 57 50
NOVOLIN R 120 68 58 113
CIPROFLOXACIN HCL 119 100 59 57
POLYETHYLENE GLYCOL 3350 119 94 59 62
AZITHROMYCIN 117 84 61 42
AMOXICILLIN 115 90 62 111
SYNTHROID 113 110 63 38
LOSARTAN POTASSIUM 110 87 64 21
AMLODIPINE BESYLATE-BENAZEPRIL 109 109 65 43
PAROXETINE HCL 107 67 66 76
BYSTOLIC 107 97 66 79
GLIMEPIRIDE 107 84 66 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 71 69 94
RAMIPRIL 99 91 70 69
CLOTRIMAZOLE-BETAMETHASONE 93 79 71 138
LOSARTAN-HYDROCHLOROTHIAZIDE 91 91 72 51
VESICARE 90 81 73 176
PROAIR HFA 90 51 73 67
NOVOLIN 70-30 90 58 73 236
DIGOXIN 88 71 76 58
JANUVIA 86 69 77 60
OXYBUTYNIN CHLORIDE 86 48 77 129
FLUOXETINE HCL 86 53 77 74
NAPROXEN 85 59 80 121
DIOVAN HCT 84 59 81 55
FLUCONAZOLE 83 52 82 139
JANTOVEN 83 51 82 147
CARBAMAZEPINE 83 48 82 258
LOVASTATIN 82 62 85 44
LANSOPRAZOLE 82 81 85 184
SPIRONOLACTONE 81 53 87 82
KLOR-CON M20 81 72 87 61
PROMETHAZINE HCL 79 67 R 89 96
ALPRAZOLAM 78 67 90 72
LEVOFLOXACIN 78 58 90 97
LEXAPRO 78 51 90 128
IRBESARTAN 77 77 93 247
AMITRIPTYLINE HCL 75 73 R 94 47
RANITIDINE HCL 75 59 94 56
SEROQUEL 73 40 96 123
METHYLPREDNISOLONE 73 55 96 93
GEMFIBROZIL 68 68 98 106
TRICOR 67 51 99 98
ONDANSETRON HCL 67 62 99 287
ZETIA 67 50 99 87
ONGLYZA 66 42 102 136
MECLIZINE HCL 63 61 103 103
LYRICA 63 55 103 77
ALENDRONATE SODIUM 62 60 105 32
FINASTERIDE 62 45 105 109
FENOFIBRATE 61 41 107 66
FAMOTIDINE 60 45 108 89
DOXAZOSIN MESYLATE 59 44 109 73
ULORIC 58 57 110 333
CLONIDINE HCL 57 28 111 36
GLYBURIDE-METFORMIN HCL 56 38 R 112 107
SPIRIVA 56 42 112 70
BUMETANIDE 55 42 114 102
MEGESTROL ACETATE 55 43 R 114 88
FLUTICASONE PROPIONATE 55 54 114 41
ROPINIROLE HCL 54 27 117 99
TERAZOSIN HCL 54 43 117 180
QUINAPRIL HCL 54 34 117 104
HALOPERIDOL DECANOATE 54 43 117 446
GLIPIZIDE 54 46 117 63
TRIAMCINOLONE ACETONIDE 53 47 122 199
MUPIROCIN 52 31 123 130
HYDRALAZINE HCL 50 24 124 71
CELEBREX 50 46 124 90
ZIPRASIDONE HCL 50 18 124 229
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.